Medpace Holdings (MEDP) Gross Profit (2015 - 2026)

Medpace Holdings (MEDP) has reported Gross Profit for 12 consecutive years, with $196.3 million the latest figure, recorded in Q1 2026.

• Gross Profit for Q1 2026 came in at $196.3 million, up 10.08% year-over-year; the trailing twelve-month figure through Mar 2026 was $778.6 million (up 14.58% YoY), and the FY2025 annual result was $760.6 million, up 15.89% from the prior year.
• Gross Profit was $196.3 million for Q1 2026 at Medpace Holdings, down from $205.3 million in the prior quarter.
• Over five years, Gross Profit peaked at $205.3 million in Q4 2025 and troughed at $98.7 million in Q1 2022.
• Average Gross Profit over 5 years is $151.2 million, with a median of $153.8 million recorded in 2024.
• Year-over-year, Gross Profit jumped 36.67% in 2022 and climbed 10.08% in 2026.
• Over 5 years, Gross Profit stood at $115.7 million in 2022, then advanced by 18.21% to $136.8 million in 2023, then surged by 30.34% to $178.3 million in 2024, then grew by 15.14% to $205.3 million in 2025, then retreated by 4.38% to $196.3 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $196.3 million in Q1 2026, $205.3 million in Q4 2025, and $196.9 million in Q3 2025.